Risk factors for cardiovascular and cerebrovascular diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 45 and 75, regardless of sex; 2. Having one or more risk factors for cardiovascular and cerebrovascular diseases: a. hypertension: systolic blood pressure >=140 mmHg and/or diastolic blood pressure >= 90mmhg; b. Diabetes: fasting blood glucose >=7.0 mmol/L or 2 hours postprandial blood glucose >= 11.1 mmol/L; c. dyslipidemia: total cholesterol >=5.2 mmol/L or low-density lipoprotein cholesterol >=3.1 mmol/L or high-density lipoprotein cholesterol = 1.7 mmol/L; d. Overweight/obesity: BMI>=24 kg/m^2 or waist circumference >=90 cm for men and >=85 cm for women. 3. Can use smart phones and other devices with unlimited Internet access, and is willing to use wearable devices; 4. Voluntary participation and signing of informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe cardiovascular and cerebrovascular diseases (such as heart failure, myocardial infarction, stroke, acute myocarditis, interventional therapy, etc. in the past 6 months) and severe arrhythmia (any of the following arrhythmia has not been treated: >=Mobitz type II second-degree atrioventricular block; Atrial fibrillation or flutter; Ventricular tachycardia and ventricular fibrillation; Paroxysmal supraventricular tachycardia); 2. Stage III hypertension (SBP cannot be controlled below 160 mmHg with three antihypertensive drugs); 3. Severe liver and kidney function diseases (alanine aminotransferase and serum creatinine indexes exceed the normal range set by the hospital by 4 times); 4. Patients with serious diseases such as malignant tumors and hematological diseases; 5. Infectious diseases such as hepatitis B, active tuberculosis and AIDS; 6. Persons with impaired physical activity or those with limited physical activity due to diseases and treatments; 7. Women who are pregnant or breastfeeding, or who have a pregnancy plan in the next 6 months; 8. People who are mentally ill and can't cooperate well; 9. It is planned to move to an area where follow-up cannot be carried out during the study; 10. other circumstances that the researcher thinks are not suitable for the group; 11. Refuse to participate in this study or sign an informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| heart rate;body weight;waist circumference;hip circumference;glycated hemoglobin (HbA1c); fasting plasma glucose;Total Cholesterol (TC);Low-Density Lipoprotein Cholesterol (LDL-C);High-Density Lipoprotein Cholesterol (HDL-C);Triglycerides (TG);serum uric acid;mean daily caloric intake;cardiovascular risk score(CHINA-PAR);Intervention satisfaction score;Exercise Adherence;Dietary Adherence; | — |
Countries
China
Contacts
Department of Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University